Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Wanli Xue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Jiaozuo Hospital of Traditional Chinese Medicine, Jiaozuo, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Stomach Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Tetrandrine (Tet), a traditional Chinese herbal medicine extract, exhibits anti‐cancer effect on many types of cancer. Nonetheless, the action mechanism of Tet in gastric cancer (GC) is still largely unclear. In the current study, proliferation, invasion, and migration of the BGC‐823 and MKN‐45 cells were effectively suppressed by Tet treatment in a dose‐dependent manner. Moreover, Tet suppressed expression of the proliferation‐associated protein PCNA, the interstitial cell phenotype N‐cadherin, and the extracellular matrix‐associated MMP‐2 and MMP‐9 in BGC‐823 and MKN‐45 cells in a dose‐dependent manner. PI3K/AKT/mTOR, a cancer promoting signaling, was inactivated by Tet in a dose‐dependent manner in BGC‐823 and MKN‐45 cells. Furthermore, our results demonstrated that the inhibition of Tet to PCNA, N‐cadherin, MMP‐2, and MMP‐9 expression was partly rescuedby AKT inhibitor or mTOR inhibitor. In animal experiments, tumor growth was inhibited by Tet administration in a dose‐dependent manner. In conclusion, the current data indicated that Tet had a critical effect on inhibiting BGC‐823 and MKN‐45 cells proliferation, migration, invasion, and tumor growth via regulating PI3K/AKT/mTOR signaling pathway, suggesting that Tet might be a potential treatment for GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Jiaozuo Hospital of Traditional Chinese Medicine, Jiaozuo, China.
- Department of Endocrinology, The People's Hospital of Jiaozuo City, Jiaozuo, China.
Zitieren
APA
Xue, W., Sun, R., Hao, Z., Xing, Z., Cheng, H., & Shao, L. (2023). Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14202
Vancouver
Xue W, Sun R, Hao Z, Xing Z, Cheng H, Shao L. Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14202
BibTeX
@article{Xue2023,
author = {Xue, Wanli and Sun, Rui and Hao, Zheng and Xing, Zhenzhen and Cheng, Hongjie and Shao, Lei},
title = {Tetrandrine inhibits migration and invasion of BGC ‐823 and MKN ‐45 cells by regulating PI3K / AKT / mTOR signaling pathway},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14202}
}
EUVIMED